Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the plantar fasciitis treatment market grown in recent years?

The market for treating plantar fasciitis has seen dynamic growth in recent years. The market value is expected to increase from $1.68 billion in 2024 to a sizeable $2.08 billion in 2025, marking a compound annual growth rate (CAGR) of 24.0%. Factors such as alternative treatment options, increased patient knowledge and consciousness, pain control strategies, a surge in sports-related injuries, and advancements in physical therapy techniques have contributed to this historic growth.

How is the plantar fasciitis treatment market size expected to evolve during the forecast period?

It is projected that the market size for treatment of plantar fasciitis will witness substantial expansion in the forthcoming years. The market is estimated to escalate to a worth of $4.73 billion by 2029 with a compound annual growth rate (CAGR) of 22.8%. This expectation of growth in the predicted period can be credited to diverse elements such as alterations in regulations and approvals, the introduction of strategies centered around the patient, research work along with clinical investigations, the emphasis on individualized medication, and an increase in the population of the elderly. The major trends anticipated during this forecast period are the growing interest in specialized recovery methodologies, the invention of new orthopedic devices, studies in biomechanics, the enhancement of alternate treatments, and focus on patient awareness and self-care.

Get your plantar fasciitis treatment market report here!

https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report

Which key drivers are propelling the plantar fasciitis treatment market’s growth?

The upswing in obesity is anticipated to catalyze the expansion of the plantar fasciitis market. Obesity, a health danger resulting from unusual or excessive fat accumulation, is defined as having a body mass index (BMI) of 25 or above, while a BMI above 30 denotes obesity. A normal weight individual’s risk of developing plantar fasciitis is nearly six times less than someone with a BMI of 30 or more. Recent data from the Centers for Disease Control and Prevention (CDC), released in 2022, shows an increase in adult obesity prevalence, now at 35% or higher in 22 states, an increase from 19 states the previous year, Thus, the escalating obesity trend is fueling the plantar fasciitis market’s growth.

What are the market segments in the plantar fasciitis treatment industry?

The plantar fasciitis treatment market covered in this report is segmented –

1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types

2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments

2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups

3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy

4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures

5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp

Which leading companies are shaping the growth of the plantar fasciitis treatment market?

Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.

What key trends are currently impacting the plantar fasciitis treatment market’s development?

The plantar fasciitis treatment market is seeing a surge in popularity due to technological innovations. Some leading businesses in this sector have started to establish and apply new technologies to overhaul treatment for plantar heel pain, and are broadening their geographical scope to maintain their place in the market. Take ZetrOZ Systems for example; this US ultrasound tech manufacturing firm launched the Sam X1 in December 2022. It is the only FDA-approved wireless ultrasound device for domestic use. It provides a new treatment option for plantar fasciitis and soft tissue damage, promoting cell growth without the need for drugs or surgery. With a proven record of treating various injuries, including plantar fasciitis, the ZetrOZ sam x1 device enriches blood vessels for better oxygen travel to the affected areas. It also removes cytokine enzymes and cells, accelerating the healing process.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9385

Which geographic areas are influencing the growth of the plantar fasciitis treatment market?

North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Biosimilar Interleukins Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-interleukin-global-market-report

Digestive Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: